NCT07116135 Speech Understanding and Listening Effort Benefits of Hearing Instruments
| NCT ID | NCT07116135 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sonova AG |
| Condition | Hearing Loss, Bilateral |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-02-05 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-02-05 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical study is to investigate the benefits of hearing instrument use in adults with hearing loss. The main questions it aims to answer are: Does hearing instrument use improve speech understanding and listening effort amount people with hearing loss? Researchers will compare varying models of hearing instruments to see how speech understanding and listening effort are impacted. Participants will be asked to wearing varying hearing instruments and participate in lab-based activities to evaluate their speech understanding, listening effort, and subjective preference.
Eligibility Criteria
Inclusion Criteria: * Adult 18-95 years * N3 or N4 hearing loss * Experienced hearing aid user * English fluency * Cognitively able to complete complex listening tasks Exclusion Criteria: * Outside of specified age range * Vulnerable populations * Hearing within normal limits or otherwise not appropriate for hearing instruments under study * Inability to read, write, or speak English * Inability to complete complex listening tasks
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07116135 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 95 Years, studying Hearing Loss, Bilateral. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07116135 currently recruiting?
Yes, NCT07116135 is actively recruiting participants. Contact the research team at ant-lab@usf.edu for enrollment information.
Where is the NCT07116135 trial being conducted?
This trial is being conducted at Tampa, United States.
Who is sponsoring the NCT07116135 clinical trial?
NCT07116135 is sponsored by Sonova AG. The trial plans to enroll 30 participants.